Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019170488> ?p ?o ?g. }
- W2019170488 endingPage "107" @default.
- W2019170488 startingPage "102" @default.
- W2019170488 abstract "A high virological response rate can often be shown to be obtained with PEG-IFN alpha-2b and ribavirin combination therapy in chronic hepatitis C patients. Viral dynamics have been utilized for the evaluation of antiviral effects, especially the exponential second decay slope, which represents the elimination of infected cells.Forty-nine patients were randomly assigned to the IFN alpha-2b group (n = 26) or the PEG-IFN alpha-2b group (n = 23). Ribavirin was administered equally to both groups. Measuring the serum concentration of HCVRNA, the exponential viral decay during phase 1 and 2 was calculated.The exponential decay slope in phase 2 during the first 2 weeks was greater in the IFN alpha-2b group than in the PEG-IFN alpha-2b group; however, from weeks 3 to 4, it was greater in the PEG-IFN alpha-2b group than in the IFN alpha-2b group. Interestingly, in the PEG-IFN alpha-2b group, the exponential decay slope was greater from weeks 3 to 4 after initiating combination therapy than during the weeks 1-2 (p < 0.01), despite administration of the same PEG-IFN alpha-2b dose (1.5 microg/kg once weekly).In PEG-IFN alpha-2b and ribavirin combination therapy, elimination of infected cells may be pronounced following an increase in serum ribavirin concentration in chronic hepatitis C patients with genotype 1b infection and a high viral load." @default.
- W2019170488 created "2016-06-24" @default.
- W2019170488 creator A5018376283 @default.
- W2019170488 creator A5018535039 @default.
- W2019170488 creator A5029463844 @default.
- W2019170488 creator A5041995869 @default.
- W2019170488 creator A5051454684 @default.
- W2019170488 creator A5051483360 @default.
- W2019170488 creator A5066924600 @default.
- W2019170488 creator A5077398626 @default.
- W2019170488 creator A5083170735 @default.
- W2019170488 creator A5084241682 @default.
- W2019170488 creator A5085351803 @default.
- W2019170488 date "2004-06-11" @default.
- W2019170488 modified "2023-09-23" @default.
- W2019170488 title "A Comparison of the Exponential Decay Slope between PEG-IFN alfa-2b/Ribavirin and IFN alfa-2b/Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Genotype 1b Infection and a High Viral Load" @default.
- W2019170488 cites W1515293536 @default.
- W2019170488 cites W1599050129 @default.
- W2019170488 cites W1675164605 @default.
- W2019170488 cites W1974441545 @default.
- W2019170488 cites W1977256895 @default.
- W2019170488 cites W1977484015 @default.
- W2019170488 cites W1985887476 @default.
- W2019170488 cites W1991257387 @default.
- W2019170488 cites W2012647968 @default.
- W2019170488 cites W2039441730 @default.
- W2019170488 cites W2043519223 @default.
- W2019170488 cites W2056597780 @default.
- W2019170488 cites W2131390487 @default.
- W2019170488 cites W2132290252 @default.
- W2019170488 cites W2142337801 @default.
- W2019170488 cites W2153918414 @default.
- W2019170488 cites W2156574153 @default.
- W2019170488 cites W2165297688 @default.
- W2019170488 cites W2171625381 @default.
- W2019170488 cites W2332630894 @default.
- W2019170488 doi "https://doi.org/10.1159/000077833" @default.
- W2019170488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15192274" @default.
- W2019170488 hasPublicationYear "2004" @default.
- W2019170488 type Work @default.
- W2019170488 sameAs 2019170488 @default.
- W2019170488 citedByCount "12" @default.
- W2019170488 countsByYear W20191704882014 @default.
- W2019170488 crossrefType "journal-article" @default.
- W2019170488 hasAuthorship W2019170488A5018376283 @default.
- W2019170488 hasAuthorship W2019170488A5018535039 @default.
- W2019170488 hasAuthorship W2019170488A5029463844 @default.
- W2019170488 hasAuthorship W2019170488A5041995869 @default.
- W2019170488 hasAuthorship W2019170488A5051454684 @default.
- W2019170488 hasAuthorship W2019170488A5051483360 @default.
- W2019170488 hasAuthorship W2019170488A5066924600 @default.
- W2019170488 hasAuthorship W2019170488A5077398626 @default.
- W2019170488 hasAuthorship W2019170488A5083170735 @default.
- W2019170488 hasAuthorship W2019170488A5084241682 @default.
- W2019170488 hasAuthorship W2019170488A5085351803 @default.
- W2019170488 hasConcept C10138342 @default.
- W2019170488 hasConcept C104317684 @default.
- W2019170488 hasConcept C126322002 @default.
- W2019170488 hasConcept C135763542 @default.
- W2019170488 hasConcept C141071460 @default.
- W2019170488 hasConcept C159047783 @default.
- W2019170488 hasConcept C162324750 @default.
- W2019170488 hasConcept C203014093 @default.
- W2019170488 hasConcept C2522874641 @default.
- W2019170488 hasConcept C2775944032 @default.
- W2019170488 hasConcept C2776178377 @default.
- W2019170488 hasConcept C2776408679 @default.
- W2019170488 hasConcept C2776999253 @default.
- W2019170488 hasConcept C2780040827 @default.
- W2019170488 hasConcept C2909179924 @default.
- W2019170488 hasConcept C3020491458 @default.
- W2019170488 hasConcept C49453240 @default.
- W2019170488 hasConcept C54400483 @default.
- W2019170488 hasConcept C55493867 @default.
- W2019170488 hasConcept C64943373 @default.
- W2019170488 hasConcept C71924100 @default.
- W2019170488 hasConcept C86803240 @default.
- W2019170488 hasConcept C90924648 @default.
- W2019170488 hasConceptScore W2019170488C10138342 @default.
- W2019170488 hasConceptScore W2019170488C104317684 @default.
- W2019170488 hasConceptScore W2019170488C126322002 @default.
- W2019170488 hasConceptScore W2019170488C135763542 @default.
- W2019170488 hasConceptScore W2019170488C141071460 @default.
- W2019170488 hasConceptScore W2019170488C159047783 @default.
- W2019170488 hasConceptScore W2019170488C162324750 @default.
- W2019170488 hasConceptScore W2019170488C203014093 @default.
- W2019170488 hasConceptScore W2019170488C2522874641 @default.
- W2019170488 hasConceptScore W2019170488C2775944032 @default.
- W2019170488 hasConceptScore W2019170488C2776178377 @default.
- W2019170488 hasConceptScore W2019170488C2776408679 @default.
- W2019170488 hasConceptScore W2019170488C2776999253 @default.
- W2019170488 hasConceptScore W2019170488C2780040827 @default.
- W2019170488 hasConceptScore W2019170488C2909179924 @default.
- W2019170488 hasConceptScore W2019170488C3020491458 @default.
- W2019170488 hasConceptScore W2019170488C49453240 @default.
- W2019170488 hasConceptScore W2019170488C54400483 @default.
- W2019170488 hasConceptScore W2019170488C55493867 @default.
- W2019170488 hasConceptScore W2019170488C64943373 @default.